Detalhe da pesquisa
1.
Targeting chromatin binding regulation of constitutively active AR variants to overcome prostate cancer resistance to endocrine-based therapies.
Nucleic Acids Res
; 43(12): 5880-97, 2015 Jul 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-25908785
2.
Harnessing Solute Carrier Transporters for Precision Oncology.
Molecules
; 22(4)2017 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-28350329
3.
TALEN-engineered AR gene rearrangements reveal endocrine uncoupling of androgen receptor in prostate cancer.
Proc Natl Acad Sci U S A
; 110(43): 17492-7, 2013 Oct 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-24101480
4.
Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex.
Cancer Res
; 83(17): 2938-2951, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37352376
5.
Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth.
J Clin Invest
; 131(10)2021 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33998604
6.
Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Spectrum of Therapeutics and Confers Vulnerability to Replication Stress.
Cell Rep
; 31(8): 107669, 2020 05 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-32460015
7.
Molecular determinants of response to high-dose androgen therapy in prostate cancer.
JCI Insight
; 4(19)2019 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31503550
8.
Supraphysiological androgens suppress prostate cancer growth through androgen receptor-mediated DNA damage.
J Clin Invest
; 129(10): 4245-4260, 2019 07 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-31310591
9.
Anti-Depressant Therapy Brightens the Outlook for Prostate Cancer Bone Metastases.
Cancer Cell
; 31(3): 303-305, 2017 03 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-28292431
10.
Exploiting AR-Regulated Drug Transport to Induce Sensitivity to the Survivin Inhibitor YM155.
Mol Cancer Res
; 15(5): 521-531, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28465296
11.
Supraphysiologic Testosterone Therapy in the Treatment of Prostate Cancer: Models, Mechanisms and Questions.
Cancers (Basel)
; 9(12)2017 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29210989
12.
Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling.
Cancer Cell
; 32(4): 474-489.e6, 2017 10 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29017058
13.
Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth.
J Clin Invest
; 131(12)2021 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34128479
14.
Interplay between genomic alterations and androgen receptor signaling during prostate cancer development and progression.
Horm Cancer
; 4(2): 61-9, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23307762
15.
Targeting G with TAL effectors: a comparison of activities of TALENs constructed with NN and NK repeat variable di-residues.
PLoS One
; 7(9): e45383, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23028976